tryptophan has been researched along with Action Myoclonus-Renal Failure Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbatova, J; D'Amato, E; Reeben, M; Vaarmann, A; Zharkovsky, A | 1 |
| Kawano, H; Matsushita, H; Ochi, M; Sakai, H; Takeuchi, Y | 1 |
2 other study(ies) available for tryptophan and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.
Topics: 3-Hydroxyanthranilic Acid; Adult; Animals; Chromatography, High Pressure Liquid; Cystatin B; Cystatins; Disease Models, Animal; Female; Humans; Kynurenine; Male; Mice; Myoclonic Epilepsies, Progressive; Serotonin; Tryptophan | 2005 |
Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
Topics: Adolescent; Age Factors; Aging; Biogenic Monoamines; Case-Control Studies; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Myoclonic Epilepsies, Progressive; Tryptophan; Tyrosine | 2001 |